Evidence map›Paper›PMID 37118707›Full record

Trial reportBMC musculoskeletal disorders2023

"Platelet-Rich Plasma" epidural injection an emerging strategy in lumbar disc herniation: a Randomized Controlled Trial.

Asarn Wongjarupong, Saran Pairuchvej, Panyajarn Laohapornsvan, Vit Kotheeranurak, Khanathip Jitpakdee, Chunrutai Yeekian, Pongsthorn Chanplakorn

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC musculoskeletal disorders, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05234840 ("Platelet-Rich Plasma" Transforaminal Epidural Injection an Emerging Strategy in Lumbar Disc Herniation), which is not on this map. Cited by 30 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 6 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05234840 nacompletednot on this map

"Platelet-Rich Plasma" Transforaminal Epidural Injection an Emerging Strategy in Lumbar Disc Herniation

TypeinterventionalSponsorQueen Savang Vadhana Memorial Hospital, ThailandRan2019 to 2021Enrolled30ConditionsPRPArmsplatelet rich plasma, Triamcinolone
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 6 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Review
  8. Article
  9. Lumbar Disc Herniation: What's New in Surgical Treatment.Revista brasileira de ortopedia · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Asarn WongjarupongDepartment of Orthopaedic, Queen Savang Vadhana Memorial Hospital, Siracha, Chonburi, Thailand.
Saran PairuchvejDepartment of Orthopaedic, Queen Savang Vadhana Memorial Hospital, Siracha, Chonburi, Thailand. runsan56@hotmail.com.ORCID http://orcid.org/0000-0003-1172-4461
Panyajarn LaohapornsvanDepartment of Orthopaedic, Queen Savang Vadhana Memorial Hospital, Siracha, Chonburi, Thailand.
Vit KotheeranurakDepartment of Orthopaedic, Queen Savang Vadhana Memorial Hospital, Siracha, Chonburi, Thailand.
Khanathip JitpakdeeDepartment of Orthopaedic, Queen Savang Vadhana Memorial Hospital, Siracha, Chonburi, Thailand.
Chunrutai YeekianDepartment of Orthopaedic, Queen Savang Vadhana Memorial Hospital, Siracha, Chonburi, Thailand.
Pongsthorn ChanplakornDepartment of orthopedic, Faculty of medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Mahidol University · THMemorial Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLumbar herniated disc (HNP) is mainly treated by conservative management. Epidural steroid injection (ESI) has been an option to treat failed cases prior to surgery. Triamcinolone has been widely used due to its efficacy in bringing about pain reduction for up to three months. However, several reports have shown some severe adverse events. Platelet-rich plasma (PRP) is made from blood through centrifugation. Several studies supported the potential short to long-term effects, and safety of PRP injection in treating HNP. The study objective was to evaluate the efficacy of PRP in treatment of single-level lumbar HNP in comparison to triamcinolone.

methodsThirty patients were treated by transforaminal epidural injections. PRP was obtained from 24 ml venous blood through standardized double-spin protocol. Participants included fifteen patients each being in triamcinolone and PRP groups. The same postoperative protocols and medications were applied. The visual analogue scale of leg (LegVAS), collected at baseline, 2, 6, 12, and 24 weeks, was the primary outcome. The BackVAS, Oswestry Disability Index (ODI), adverse event, and treatment failure were the secondary endpoints.

resultsPlatelet ratio of PRP in fifteen patients was 2.86 ± 0.85. Patients treated by PRP injections showed statistically and clinically significant reduction in LegVAS at 6, 12, and 24 weeks, and in ODI at 24 weeks. It demonstrated comparable results on other aspects. No adverse event occurred in either group.

conclusionNoncommercial epidural double-spin PRP yielded superior results to triamcinolone. Due to its efficacy and safety, the procedure is recommended in treating single level lumbar HNP.

trial registrationNCT, NCT05234840. Registered 1 January 2019, https://clinicaltrials.gov/ct2/show/record/NCT05234840 .

Indexed as

Intervertebral Disc DisplacementHumansInjections, EpiduralLumbar VertebraePainTreatment OutcomeTriamcinoloneTriamcinoloneESILumbar HNPPlatelet-rich plasmaPRPTriamcinoloneVAS

Identifiers

PMID37118707
PMCPMC10141936
OpenAlexW4367300038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.